Cara Therapeutics Raises $19 Million

Cara Therapeutics Inc., a Tarrytown, N.Y.-based drug company focused on pain and inflammation associated with diverse medical conditions, has raised $19 million in Series C funding. MVM Life Science Partners and Alta Biopharm Partners were joined by return backer Ascent Biomedical Ventures. www.caratherapeutics.com